How you do approach adjuvant radiation recommendations (RAI and EBRT) for papillary thyroid carcinoma, tall cell variant status-post total thyroidectomy?

TCV remains the most common high risk pathological variant of well differentiated papillary thyroid cancer and often is associated with a BRAF mutation, which makes it more likely a target for systemic therapy if and when it recurs.

From a postop RT perspective, it is more likely to recur both at the...